• Elfa Medicamentos’ board met Sept. 21, 2026 to correct the post-conversion ordinary share count by including treasury shares.
• Total ordinary shares were restated to 1,895,915,714,524,830 from 1,895,915,698,318,960.
• Treasury stock was confirmed at 16,205,870 ordinary shares, previously excluded from the stated total.
• The board also amended the Sept. 18, 2026 board minutes to reflect the corrected share count, ratifying other prior resolutions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elfa Medicamentos SA published the original content used to generate this news brief on September 22, 2026, and is solely responsible for the information contained therein.